⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GMAB News
Genmab A/S ADS
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
globenewswire.com
GMAB
Tissue Factor-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025: Tivdak Has Become the Benchmark for Improved Next Generation ADCs in Non-clinical and Clinical Development
globenewswire.com
PFE
GMAB
Genmab Announces EPKINLY ® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma
businesswire.com
GMAB
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
businesswire.com
GMAB
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S ®) in Advanced Endometrial Cancer (EC)
businesswire.com
GMAB